'Vaccines As Tools To Combat Antimicrobial Resistance' is due to take place as an in-person meeting on 27–28 February 2023, at Edgbaston Park Hotel and Conference Centre in Birmingham, UK.
COVID-19 demonstrates the devastation of infection when treatment options are limited. The pandemic also demonstrates how vaccines normalise social and economic freedom and equality. Antimicrobial resistance (AMR) has a greater potential to impact our lives.
AMR is a growing global problem, with 1.27 million deaths attributable to AMR bacteria annually. Vaccines can impact AMR by preventing infections and reducing the need for antibiotics which will slow the emergence of AMR.
There are no vaccines, or extant vaccines are sub-optimal, against many human-specific or veterinary/zoonotic bacterial infections. Generating new vaccines for bacterial pathogens is complex. The antigen content, delivery platform and host immune status all influence vaccine development, cost, pathogen evasion and use. Therefore, successful vaccine development requires combined expertise in microbiology (antigen selection), chemistry (platform technology) and host response (immunology). This meeting will address these key areas along the AMR-vaccine platform-veterinary/human immunology axis.
Key topics
- AMR – the problem in the context of human and veterinary health
- The strengths and gaps in using vaccination to limit AMR
- Host responses to different bacterial antigens and vaccines – key lessons learned
- Enhancing the use of existing and novel platforms, technologies, adjuvants – the spectre of ‘Pathogen X’
- The targeting of bacterial pathogens to reduce AMR – addressing unmet needs.
Early bird rates for this event will end on 16 January.
Read more and register for the event here – https://microbiologysociety.org/event/society-events-and-meetings/vaccines-as-tools-to-combat-antimicrobial-resistance.html